Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 1096 AL 1110

Anesthesia, surgery, illness and Alzheimer's disease

Eckenhoff RG, Laudansky KF.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:162-6. doi: 10.1016/j.pnpbp.2012.06.011. Epub 2012 Jun 21.

Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT

Makedonov I, Black SE, MacIntosh BJ.

Eur J Neurol. 2013 Feb;20(2):243-50. doi: 10.1111/j.1468-1331.2012.03785.x. Epub 2012 Jun 28.

Tau protein kinases: involvement in Alzheimer's disease

Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Yardin C, Terro F.

Ageing Res Rev. 2013 Jan;12(1):289-309. doi: 10.1016/j.arr.2012.06.003. Epub 2012 Jun 26.

A noradrenergic theory of cognitive reserve: implications for Alzheimer's disease

Robertson IH.

Neurobiol Aging. 2013 Jan;34(1):298-308. doi: 10.1016/j.neurobiolaging.2012.05.019. Epub 2012 Jun 27.

Exercise counteracts declining hippocampal function in aging and Alzheimer's disease

Intlekofer KA, Cotman CW.

Neurobiol Dis. 2013 Sep;57:47-55. doi: 10.1016/j.nbd.2012.06.011. Epub 2012 Jun 30.

A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes

Muñoz-Nieto M, Ramonet N, López-Gastón JI, Cuadrado-Corrales N, Calero O, Díaz-Hurtado M, Ipiens JR, Ramón y Cajal S, de Pedro-Cuesta J, Calero M.

J Neurol. 2013 Jan;260(1):77-84. doi: 10.1007/s00415-012-6588-1. Epub 2012 Jul 5.

Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A

Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Terro F.

Ageing Res Rev. 2013 Jan;12(1):39-49. doi: 10.1016/j.arr.2012.06.008. Epub 2012 Jul 6.

Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD

García-Barroso C, Ricobaraza A, Pascual-Lucas M, Unceta N, Rico AJ, Goicolea MA, Sallés J, Lanciego JL, Oyarzabal J, Franco R, Cuadrado-Tejedor M, García-Osta A.

Neuropharmacology. 2013 Jan;64:114-23. doi: 10.1016/j.neuropharm.2012.06.052. Epub 2012 Jul 7.

Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer's disease

Chang WW, Zhang L, Jin YL, Yao YS.

J Neural Transm (Vienna). 2013 Feb;120(2):353-60. doi: 10.1007/s00702-012-0850-7. Epub 2012 Jul 11.

Four-repeat tau-selective deposition in subthalamic nucleus and motor cortex in Alzheimer disease

Takeda T, Sato T, Ito T, Sumi Y, Kobayashi T, Kitagawa M, Hirokawa K, Uchihara T.

Clin Neurol Neurosurg. 2013 May;115(5):641-3. doi: 10.1016/j.clineuro.2012.06.030. Epub 2012 Jul 15.

Providing quality palliative care in end-stage Alzheimer disease

Yeaman PA, Ford JL, Kim KY.

Am J Hosp Palliat Care. 2013 Aug;30(5):499-502. doi: 10.1177/1049909112453644. Epub 2012 Jul 18.

Dopamine D₂-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients

Martorana A, Di Lorenzo F, Esposito Z, Lo Giudice T, Bernardi G, Caltagirone C, Koch G.

Neuropharmacology. 2013 Jan;64:108-13. doi: 10.1016/j.neuropharm.2012.07.015. Epub 2012 Aug 1.

What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research

Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P.

J Neural Transm (Vienna). 2013 Jan;120(1):233-52. doi: 10.1007/s00702-012-0877-9. Epub 2012 Aug 12.

Towards a bioinformatics analysis of anti-Alzheimer's herbal medicines from a target network perspective

Sun Y, Zhu R, Ye H, Tang K, Zhao J, Chen Y, Liu Q, Cao Z.

Brief Bioinform. 2013 May;14(3):327-43. doi: 10.1093/bib/bbs025. Epub 2012 Aug 11.

Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia

Berridge MJ.

Prion. 2013 Jan-Feb;7(1):2-13. doi: 10.4161/pri.21767. Epub 2012 Aug 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias